Söndag 20 April | 16:55:11 Europe / Stockholm

Prenumeration

2025-04-09 07:49:00

Redeye sees an interesting opportunity in Transtema, which is trading close to its four-year low despite momentum in its Swedish operations. At worst, Transtema has a slight indirect exposure to geopolitical turmoil, but the share has declined ~15% YTD.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/